Xucox 90 Tablet contains Etoricoxib 90 mg, a selective cyclooxygenase-2 (COX-2) inhibitor used primarily for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. Etoricoxib works by selectively inhibiting the COX-2 enzyme, which plays a key role in the synthesis of prostaglandins responsible for inflammation and pain, thereby providing effective symptomatic relief while minimizing gastrointestinal side effects commonly associated with non-selective nonsteroidal anti-inflammatory drugs (NSAIDs). Xucox 90 is indicated for short-term and long-term treatment of chronic inflammatory conditions and acute pain episodes. The recommended dosage should be individualized based on the patient’s clinical condition and response to therapy, with caution advised in patients with cardiovascular risk factors, renal or hepatic impairment. It is contraindicated in patients with known hypersensitivity to Etoricoxib, active peptic ulceration, or severe heart failure. Regular monitoring of renal function, liver enzymes, and blood pressure is recommended during prolonged therapy. Patients should be advised to report any signs of gastrointestinal bleeding, cardiovascular symptoms, or allergic reactions promptly. Xucox 90 Tablet should be used under medical supervision to ensure optimal therapeutic outcomes and safety.